<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03893396</url>
  </required_header>
  <id_info>
    <org_study_id>2018/P02/283</org_study_id>
    <nct_id>NCT03893396</nct_id>
  </id_info>
  <brief_title>Safety Assessment of Angioplasty Procedures</brief_title>
  <acronym>SCRAP</acronym>
  <official_title>Safety Assessment of Angioplasty Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier de la Rochelle Ré Aunis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BBraun Medical SAS</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Hospitalier de la Rochelle Ré Aunis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic heart disease, or coronary heart disease, covers a set of pathologies due to
      insufficient oxygen supply to the myocardium due to the development of atherosclerosis in one
      or more coronary arteries. To evaluate the safety of angioplasty performed in patients
      operated on at La Rochelle Hospital, the rate of major adverse cardiac events (MACE) will be
      determined and compared with data from the literature.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of active stents for the treatment of coronary stenosis is currently the standard
      treatment in almost all types of coronary lesions. In percutaneous transluminal treatment of
      coronary lesions, balloon angioplasty and bare stents have not shown satisfactory results in
      the past. The so-called active drug-eluting balloon could represent a new therapeutic option
      for the treatment of de novo lesions.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Number of major adverse cardiac events (MACE)</measure>
    <time_frame>12 months</time_frame>
    <description>The primary endpoint is a composite endpoint that includes major adverse cardiac events defined as cardiovascular death, non-fatal myocardial infarction (MI), non-fatal stroke (stroke) and revascularization of target lesion (TLR) within 12 months of surgery.</description>
  </primary_outcome>
  <enrollment type="Actual">984</enrollment>
  <condition>Angiospastic; Disorder</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coronary angioplasty</intervention_name>
    <description>Procedure used to open clogged heart arteries. Involves the insertion of a tiny balloon and/or a stent to widen the artery.</description>
    <other_name>Percutaneous coronary</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for coronary angiography for revascularization are those for whom a
        diagnosis of acute (Acute Coronary Syndrome with or without ST segment elevation) or
        chronic (Silent myocardial ischemia, angina) coronary pathology has been made
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Interventional revascularization of a coronary lesion,

          -  Member or beneficiary of a social security system,

          -  Informed of the study.

        Exclusion Criteria:

          -  Language barrier,

          -  Minor,

          -  Pregnant woman,

          -  Person under guardianship,

          -  Person deprived of his/her liberty,

          -  Refusal to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ludovic MEUNIER, MD</last_name>
    <role>Study Director</role>
    <affiliation>Groupe Hospitalier de la Rochelle Ré Aunis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier de la Rochelle Ré Aunis</name>
      <address>
        <city>La Rochelle</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2019</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>drug eluting stent</keyword>
  <keyword>Drug-coated balloon</keyword>
  <keyword>Bare-Metal Stent</keyword>
  <keyword>Revascularization</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

